Nykode Therapeutics Denmark A/S — Credit Rating and Financial Key Figures

Nykode Therapeutics Denmark A/S (CVR number: 42038660) is a company from LYNGBY-TAARBÆK. The company recorded a gross profit of 52.9 mDKK in 2023. The operating profit was 3833.3 kDKK, while net earnings were 2484.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 21.8 %, which can be considered excellent and Return on Equity (ROE) was 60.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 26.1 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Nykode Therapeutics Denmark A/S's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.